Caseware UK (AP4) 2025.0.111 2025.0.111 2025-08-31 2025-08-31 2 2024-09-01 false 2 The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.Specialists medical practice activities false false 15064933 2024-09-01 2025-08-31 15064933 2023-08-11 2024-08-31 15064933 2025-08-31 15064933 2024-08-31 15064933 c:Director1 2024-09-01 2025-08-31 15064933 d:CurrentFinancialInstruments d:WithinOneYear 2025-08-31 15064933 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 15064933 d:ShareCapital 2025-08-31 15064933 d:ShareCapital 2023-08-11 2024-08-31 15064933 d:ShareCapital 2024-08-31 15064933 d:RetainedEarningsAccumulatedLosses 2024-09-01 2025-08-31 15064933 d:RetainedEarningsAccumulatedLosses 2025-08-31 15064933 d:RetainedEarningsAccumulatedLosses 2023-08-11 2024-08-31 15064933 d:RetainedEarningsAccumulatedLosses 2024-08-31 15064933 c:Micro-entities 2024-09-01 2025-08-31 15064933 c:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 15064933 c:FullAccounts 2024-09-01 2025-08-31 15064933 c:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 15064933 e:PoundSterling 2024-09-01 2025-08-31 iso4217:GBP xbrli:pure

Registered number: 15064933 BIDAYE ENT SURGERY LTD UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 31 AUGUST 2025
BIDAYE ENT SURGERY LTD REGISTERED NUMBER: 15064933 BALANCE SHEET AS AT 31 AUGUST 2025
|  | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  |  |  |  |
Tangible assets |  |  | 2,274 |  | 2,012
Current assets |  |  |  |  |
Debtors |  | 9,530 |  | - |
Current asset investments |  | 10,435 |  | - |
Cash at bank and in hand |  | 131,775 |  | 39,287 |
|  | 151,740 |  | 39,287 |
Creditors: amounts falling due within one year |  | (31,420) |  | (9,384) |
Net current assets |  |  | 120,320 |  | 29,903
Net assets |  |  | 122,594 |  | 31,915
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 1 |  | 1
Profit and loss account |  |  | 122,593 |  | 31,914
|  |  | 122,594 |  | 31,915
Page 1
BIDAYE ENT SURGERY LTD REGISTERED NUMBER: 15064933 BALANCE SHEET (CONTINUED) AS AT 31 AUGUST 2025 Notes
General information
Bidaye Ent Surgery Ltd is a private company, limited by shares, incorporated in England, United Kingdom. The registered office address is 6th Floor, 2 London Wall Place, London, EC2Y 5AU. The principal activity of the Company is that of specialists medical practice activities. The financial statements are for the year ended 31 August 2025. The figures for 2024 are for the period from incorporation on 11 August 2023 to 31 August 2024 and are therefore not entirely comparable.
Average number of employees
The average monthly number of employees, including directors, during the year was 2 (2024 - 2). Directors' confirmations The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
Dr Rohan Bidaye
Director
Date: 24 August 2026
Page 2
BIDAYE ENT SURGERY LTD STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31 AUGUST 2025
| Called up share capital | Profit and loss account | Total equity
| £ | £ | £
Comprehensive income for the period |  |  |
Profit for the period | - | 33,914 | 33,914
Contributions by and distributions to owners |  |  |
Dividends: Equity capital | - | (2,000) | (2,000)
Shares issued during the period | 1 | - | 1
At 1 September 2024 | 1 | 31,914 | 31,915
Comprehensive income for the year |  |  |
Profit for the year | - | 91,679 | 91,679
Contributions by and distributions to owners |  |  |
Dividends: Equity capital | - | (1,000) | (1,000)
At 31 August 2025 | 1 | 122,593 | 122,594
Page 3